Cargando…
Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
There is good evidence to suggest that dose intensity is important when considering the effectiveness of adjuvant chemotherapy in patients with breast cancer. However, the development of chemotherapy-induced febrile neutropenia can lead to reduction in dose intensity and other treatment modification...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752223/ https://www.ncbi.nlm.nih.gov/pubmed/19756005 http://dx.doi.org/10.1038/sj.bjc.6605269 |